Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure.
about
Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a.Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPaseReview of novel therapeutic targets for improving heart failure treatment based on experimental and clinical studiesCardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem CellsGene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationModel-specific selection of molecular targets for heart failure gene therapyGene delivery technologies for cardiac applications'Ryanopathy': causes and manifestations of RyR2 dysfunction in heart failureGene therapy targets in heart failure: the path to translationCalcium-regulated transcriptional pathways in the normal and pathologic heartCharacterization of regional left ventricular function in nonhuman primates using magnetic resonance imaging biomarkers: a test-retest repeatability and inter-subject variability studyThe fibrosis-cell death axis in heart failureCardiac adenoviral S100A1 gene delivery rescues failing myocardiumImprovement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failureTargeted inhibition of calcineurin attenuates cardiac hypertrophy in vivoHeart failure-inducible gene therapy targeting protein phosphatase 1 prevents progressive left ventricular remodelingPhosphorylation of the cAMP-dependent protein kinase (PKA) regulatory subunit modulates PKA-AKAP interaction, substrate phosphorylation, and calcium signaling in cardiac cellsSERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathwayPost-translational Modifications in Heart Failure: Small Changes, Big ImpactGene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications.Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.Intermolecular failure of L-type Ca2+ channel and ryanodine receptor signaling in hypertrophy.Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a.Alpha1A-adrenergic receptor-directed autoimmunity induces left ventricular damage and diastolic dysfunction in rats.Heart failure management: the present and the future.Cytosolic H2O2 mediates hypertrophy, apoptosis, and decreased SERCA activity in mice with chronic hemodynamic overload.Altered intracellular Ca2+ handling in heart failure.Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathyRescue of familial cardiomyopathies by modifications at the level of sarcomere and Ca2+ fluxes.Compensatory and decompensatory alterations in cardiomyocyte Ca2+ dynamics in hearts with diastolic dysfunction following aortic banding.Assessment of cardiovascular fibrosis using novel fluorescent probes.Meeting Koch's postulates for calcium signaling in cardiac hypertrophy.AFos dissociates cardiac myocyte hypertrophy and expression of the pathological gene programSERCA2a gene transfer enhances eNOS expression and activity in endothelial cells.Decoding calcium signals involved in cardiac growth and function.Phospholamban and cardiac contractility.Gene delivery of sarcoplasmic reticulum calcium ATPase inhibits ventricular remodeling in ischemic mitral regurgitationCatheter-based antegrade intracoronary viral gene delivery with coronary venous blockade.Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy.Comparative analysis of parvalbumin and SERCA2a cardiac myocyte gene transfer in a large animal model of diastolic dysfunction.
P2860
Q22010899-963D73ED-5820-460A-B874-726ED448DDD8Q24307062-DD8C8EB6-EB33-4BC5-B0DE-C7EE915275FCQ26746907-1EA62C6F-4246-4689-B187-FFB8D2A1F799Q26798131-D78F9E07-1790-4379-B2CB-08EEFD352F44Q26799437-23CEB023-D48D-4368-8B99-B43EBB4E894FQ26823061-FACD0669-1119-47E4-9542-B4287E1490F4Q26863362-EBFD8ED7-9373-4BB3-A50F-2BBDBE485759Q26865421-8674F738-8535-446E-B222-18B23A23A2B3Q27022444-A97EC85E-6D5D-4245-A8DB-F93EB487448EQ27022874-CC2C1013-0386-43BF-87AE-1138F4066EFCQ27306035-D8D258EB-141F-4B57-AC28-8341234FF61BQ28076570-36883E0F-C745-4290-99C3-BE69795B7FE4Q28296403-A4315DB3-95FC-4960-8F56-CDE49E7D3393Q28354203-0D663272-D915-4578-8CBB-8D2BBB42A54FQ28360110-402279B2-E244-4B50-9046-6D60B4803CA2Q28482901-93C3E37E-325D-4175-A368-8D767D171A29Q28567831-CBA33451-CDDE-403C-A420-21BED1A688F3Q28854278-FB68FAF1-931B-4075-8D0F-7CF8E0B9A466Q30383732-B1771B8D-66EF-4C98-AB84-2B1DE3B6DDCEQ30427066-319699C4-377D-45A5-B162-19174216E9F2Q30539904-4E449DAC-3299-4502-BAB5-9CED1810362DQ33268754-03FAB465-0C6A-4F8F-97D8-03FA2940665DQ33489603-7B1BF9B5-A6BB-4665-B2F9-74D5655A6BC6Q33535920-6AD837C6-7D4D-4BD6-B48A-04C6E5A067E3Q33605156-6DEE7F29-618E-4440-B02F-4EF4D4E3FD4DQ33626525-A7FF9268-8110-4B3E-A623-2B5E02B0C61FQ33683757-77F3FE21-A75A-4967-94ED-CD485BB42CEBQ33727613-E554744A-A9B9-4279-988E-145FD2C82286Q33787794-344D5534-79AE-4BED-B976-3BAAD0722703Q33800047-F43D66B0-7E63-44AB-9AD8-FC09DA9B7D8DQ33886088-BECFA601-BBDA-4C4B-AA1A-5F15394B6D9AQ33919182-659F870A-E4B5-49AD-B357-B7191E6C3E4EQ33947442-9887C330-055A-4DF8-A26C-1F530DD6EF08Q34025110-0D89DC11-CC77-4D4F-A966-BB78CC372B5DQ34076156-40FED601-CC30-4D57-BA55-24424164FB9EQ34111907-9394B0DC-E586-43A5-852D-5215E86D4331Q34130135-F119EDA6-4A29-4486-B1BC-2615D9DAE78BQ34191737-D2317096-5A44-4D12-BC24-6CA23A96D205Q34313853-E1E4460A-D66C-4012-9FD9-FE6980F6EC6AQ34321370-5B529B0C-2D4A-41FE-AD55-EDEC2EE798A6
P2860
Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Adenoviral gene transfer of SE ...... n transition to heart failure.
@ast
Adenoviral gene transfer of SE ...... n transition to heart failure.
@en
Adenoviral gene transfer of SE ...... n transition to heart failure.
@nl
type
label
Adenoviral gene transfer of SE ...... n transition to heart failure.
@ast
Adenoviral gene transfer of SE ...... n transition to heart failure.
@en
Adenoviral gene transfer of SE ...... n transition to heart failure.
@nl
prefLabel
Adenoviral gene transfer of SE ...... n transition to heart failure.
@ast
Adenoviral gene transfer of SE ...... n transition to heart failure.
@en
Adenoviral gene transfer of SE ...... n transition to heart failure.
@nl
P2093
P2860
P921
P356
P1476
Adenoviral gene transfer of SE ...... n transition to heart failure.
@en
P2093
A Rosenzweig
F del Monte
J K Gwathmey
J L Guerrero
M I Miyamoto
R J Hajjar
T S DiSalvo
P2860
P304
P356
10.1073/PNAS.97.2.793
P407
P577
2000-01-01T00:00:00Z